Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

NCT02562482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

NIH

Sponsor class

Conditions

Chikungunya Virus Infection

Interventions

BIOLOGICAL: VRC-CHKVLP059-00-VP
OTHER: VRC-PBSPLA043-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)